Back to Search
DAVID CARBONE, MD, PHD
MD, PHD
Medical Oncology Physician
NPI: 1558453977IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35.120481(OH)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
35.120481(OH)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1985
Research & Publications (20)
Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.
PMID 18840677·Mol Pharmacol·2009
7-preclinical
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
PMID 19493905·Carcinogenesis·2009
7-preclinical
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.
PMID 19276291·Clin Cancer Res·2009
3-trial
X-ray structure analysis of free-standing lipid membranes facilitated by micromachined apertures.
PMID 18370435·Langmuir·2008
8-other
Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP.
PMID 18508038·Brain Res·2008
7-preclinical
Versatile vacuum chamber for in situ surface X-ray scattering studies.
PMID 18552436·J Synchrotron Radiat·2008
8-other
Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas.
PMID 18566219·Mol Cancer Ther·2008
7-preclinical
In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal.
PMID 19548352·Chem Res Toxicol·2008
7-preclinical
Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed.
PMID 17922127·Cancer Chemother Pharmacol·2008
8-other
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
PMID 18167337·Cancer Cell·2008
7-preclinical
The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells.
PMID 18041089·J Neurosci Res·2008
7-preclinical
Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways.
PMID 18335517·J Neurosci Res·2008
7-preclinical
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
PMID 18349398·J Clin Oncol·2008
3-trial
Adenosine receptors in regulation of dendritic cell differentiation and function.
PMID 18559975·Blood·2008
7-preclinical
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.
PMID 18757331·J Clin Oncol·2008
3-trial
[The Macklin effect in the etiology for pneumediastinum in chest trauma].
PMID 19044255·Recenti Prog Med·2008
5-case
Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
PMID 18449013·J Thorac Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 W 10TH AVE
COLUMBUS, OH 43210 - Phone
- (614) 293-5066
Quick Facts
- NPI
- 1558453977
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile